UK Covid-19 variant has significantly higher death rate, study finds

The B.1.1.7 variant was first detected in Britain in September 2020, and has since also been found in more than 100 other countries

Coronavirus, Covid-19
"Coupled with its ability to spread rapidly, this makes B.1.1.7 a threat that should be taken seriously," said Robert Challen, a researcher at Exeter University who co-led the research | Photo: Shutterstock
Reuters
2 min read Last Updated : Mar 10 2021 | 8:31 PM IST
A highly infectious variant of Covid-19 that has spread around the world since it was first discovered in Britain late last year is between 30% and 100% more deadly than previous dominant variants, researchers said on Wednesday.
 
In a study that compared death rates among people in Britain infected with the new SARS-CoV-2 variant - known as B.1.1.7 - against those infected with other variants of the Covid-19-causing virus, scientists said the new variant's mortality rate was "significantly higher".
 
It has 23 mutations in its genetic code - a relatively high number - and some of them have made it far more easily spread.
Scientists say it is about 40%-70% more transmissible than previous dominant variants that were circulating.
 
In the UK study, published in the British Medical Journal on Wednesday, infection with the new variant led to 227 deaths in a sample of 54,906 Covid-19 patients, compared with 141 among the same number of patients infected with other variants.
 
"Coupled with its ability to spread rapidly, this makes B.1.1.7 a threat that should be taken seriously," said Robert Challen, a researcher at Exeter University who co-led the research.
 
Independent experts said this study's findings add to previous preliminary evidence linking infection with the B.1.1.7 virus variant with an increased risk of dying from Covid-19.
 
Initial findings from the study were presented to the UK government earlier this year, along with other research, by experts on its New and Emerging Respiratory Virus Threats Advisory Group, or NERVTAG, panel.
 
Lawrence Young, a virologist and professor of molecular oncology at Warwick University, said the precise mechanisms behind the higher death rate of the B.1.1.7 variant were still not clear, but "could be related to higher levels of virus replication as well as increased transmissibility".
 
He warned that the UK variant was likely fuelling a recent surge in infections across Europe.
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusUKBritainCoronavirus Vaccine

Next Story